Türkiye Sinai Kalkinma Bankasi A.S. (IST:TSKB)

Sage Therapeutics Revenue

Türkiye Sinai Kalkinma Bankasi A.S. had revenue of 5.49B TRY in the quarter ending June 30, 2025, with 42.43% growth. This brings the company's revenue in the last twelve months to 19.56B, up 51.89% year-over-year. In the year 2024, Türkiye Sinai Kalkinma Bankasi A.S. had annual revenue of 16.48B with 49.53% growth.

• Revenue (ttm): 19.56B
• Revenue Growth: +51.89%
• P/S Ratio: 1.92
• Revenue / Employee: 30.00M
• Employees: 652
• Market Cap: 37.46B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	16.48B	5.46B	49.53%
Dec 31, 2023	11.02B	4.87B	79.25%
Dec 31, 2022	6.15B	4.01B	187.11%
Dec 31, 2021	2.14B	873.36M	68.87%
Dec 31, 2020	1.27B	99.28M	8.49%